NCT07416188 2026-04-17Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent GlioblastomaNational Institutes of Health Clinical Center (CC)Phase 1/2 Not yet recruiting40 enrolled
NCT06329570 2026-04-09Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM)NaviFUS CorporationPhase 1/2 Recruiting10 enrolled